Policy

The United States reports a record 3000 daily coronavirus disease 2019 (COVID-19) deaths; the House of Representatives passes bill in support of marijuana research; data show rises in prescription drug list prices.

This episode of Managed Care Cast is a preview of an interview with Michael E. Chernew, PhD, and A. Mark Fendrick, MD, the co-editors-in-chief of The American Journal of Managed Care®, which appears in the December issue of the journal.

The United Kingdom administers the first doses of Pfizer's coronavirus disease 2019 (COVID-19) vaccine; an FDA review confirms the safety and efficacy of Pfizer's vaccine; Fauci advises holiday gatherings be limited to 10 or less people.

With leading health experts warning of a grim few months ahead as the pandemic continues to rage, and as a vaccine launch grows more imminent, this 3-part series explores the impact of existing health disparities on COVID-19 and some potential solutions.

The Dutch study sought to add to what is known about the cost-effectiveness of shared decision-making in multiple sclerosis.

President-elect Joe Biden will call for 100 days of mask-wearing on inauguration day; HHS announces maternal morbidity action plan; Pelosi, McConnell in virus relief talks.

In the span of a few weeks, Pfizer, Moderna, and AstraZeneca all announced positive results from their respective coronavirus disease 2019 (COVID-19) vaccine trials, with Pfizer submitting to FDA for an emergency use authorization (EUA) on November 20.

Recently released vaccine data indicate encouraging steps forward in the global fight against coronavirus disease 2019 (COVID-19). When vaccine doses first become available, who should be prioritized?

While death rates related to HIV infection declined from 2010 to 2017, differences in HIV-related deaths remain among certain populations.

President Donald Trump issued 2 orders Friday aiming to lower drug prices paid by Medicare by invoking a "most favored nations" policy and also by targeting rebates paid to pharmacy benefit managers.

Pfizer will submit an emergency use authorization for their coronavirus disease 2019 (COVID-19) vaccine; WHO panel recommends against remdesivir; CDC urges Americans to stay put during Thanksgiving.

On this episode of Managed Care Cast, we speak with the president and CEO of the Leapfrog Group about her organization’s partnership with the Healthcare Transformation Alliance and how transparency and employer leverage may shape the transition toward value-based health care.

Expansion of insurance coverage due to the Affordable Care Act led to a reduction in the use of emergency services for patients with asthma in New York City.

Switching patients from pressurized metered dose inhalers (pMDIs) to dry powder inhalers (DPIs) could both reduce health care system’s carbon footprint and result in more satisfied patients.

During a webinar, experts discussed where health care has improved life expectancy and the relationship between cost and relative contribution that each area makes to life improvement and expectancy.

During oral arguments, the justices asked skeptical questions regarding Republican state efforts to get the Affordable Care Act (ACA) overturned.

Pfizer said interim data on its coronavirus disease 2019 (COVID-19) vaccine show 90% efficacy; meanwhile, President-elect Joe Biden released the names of his coronavirus advisory board.

This study, which provides the first description of episode spending patterns for safety-net hospitals nationwide, demonstrates that episode spending does not vary by safety-net status.

Although the fate of the Senate remains undecided, President-elect Joe Biden’s Democratic win spells major changes for both the handling of the coronavirus disease 2019 pandemic and health care in the United States.

This week, the top news in managed care included top health care takeaways from the 2020 general election; a Q&A with Dr William Shrank on connecting Medicare Advantage providers and patients; Managed Care Cast discusses balancing evidence with action amid the COVID-19 pandemic.

Although a winner has yet to be declared in the 2020 presidential race, several ballot measures and state level races yielded results with major implications in the health care field. Below is a list of the most influential health care–related outcomes of the 2020 elections.

There is a lot of uncertainty among providers participating in federal alternative payment models (APMs) given the general election and the upcoming Supreme Court case on the Affordable Care Act (ACA).

As novel therapies drive up the cost of cancer care, federal policy decisions are being made that influence oncologists' ability to deliver cancer care, said Debra Patt, MD, PhD, MBA, MPH, of Texas Oncology.

The study offers the first de novo cost-effectiveness model of these patients in the United States, according to the researchers.

The Trump administration finalized rules aimed at making health care pricing more visible and transparent to those with with health insurance from employers or the individual market.